Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Affinity Asset Advisors, LLC reported a 8.60% stake in Karyopharm Therapeutics Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 14, 2026
Affinity Asset Advisors, LLC reported a 8.60% stake in Karyopharm Therapeutics Inc., 2,073,517 shares, as a passive investor on Mar 31, 2026. Filed May 14, 2026 (Schedule 13G/A).
- Stake
- 8.60%
- Shares
- 2,073,517
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Affinity Asset Advisors, LLC | 8.60% | 2,073,517 |
| Michael Cho | 8.60% | 2,073,517 |
Source
Related
- Karyopharm Therapeutics Inc.
- Affinity Asset Advisors, LLC
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G/A · Affinity Asset Advisors, LLC · Jan 29, 2026
- Schedule 13G · Affinity Asset Advisors, LLC · Apr 10, 2025
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026